DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,200 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,732 | -7.9% | 761 | -10.9% | 0.04% | -7.9% |
| Q2 2023 | $204,877 | -4.0% | 854 | +0.8% | 0.04% | 0.0% |
| Q1 2023 | $213,375 | +80.8% | 847 | +61.3% | 0.04% | +22.6% |
| Q1 2021 | $118,000 | +76.1% | 525 | +38.5% | 0.03% | +40.9% |
| Q2 2020 | $67,000 | +28.8% | 379 | 0.0% | 0.02% | +4.8% |
| Q1 2020 | $52,000 | -10.3% | 379 | 0.0% | 0.02% | +10.5% |
| Q4 2019 | $58,000 | +5.5% | 379 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $55,000 | +1.9% | 379 | 0.0% | 0.02% | -5.0% |
| Q2 2019 | $54,000 | +8.0% | 379 | 0.0% | 0.02% | -4.8% |
| Q1 2019 | $50,000 | +28.2% | 379 | 0.0% | 0.02% | +5.0% |
| Q4 2018 | $39,000 | -4.9% | 379 | 0.0% | 0.02% | +5.3% |
| Q3 2018 | $41,000 | +10.8% | 379 | +0.3% | 0.02% | -9.5% |
| Q2 2018 | $37,000 | 0.0% | 378 | 0.0% | 0.02% | -4.5% |
| Q1 2018 | $37,000 | +23.3% | 378 | +16.0% | 0.02% | 0.0% |
| Q4 2017 | $30,000 | – | 326 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |